You are currently viewing a new version of our website. To view the old version click .

MRI and PET Imaging in Neuro-Oncology—Current Developments and Clinical Translation

This special issue belongs to the section “Cancer Biomarkers“.

Special Issue Information

Dear Colleagues,

Imaging biomarkers by means of magnetic resonance imaging (MRI) and positron emission tomography (PET) techniques are increasingly applied in the clinic, with a fast-growing body of evidence regarding their diagnostic value in neuro-oncology. In contrast to biochemical or histological markers, the key advantages of imaging biomarkers are the non-invasive nature and spatial and temporal resolution of these approaches. This Special Issue of Cancers focuses on new technical developments and clinical applications of novel MR biomarkers in humans, with a strong focus on neuro-oncologic diseases. These include both validation studies with clinically established biomarkers and novel approaches that have recently demonstrated high potential for clinical utility.

Prof. Dr. Daniel Paech
Dr. Manuel Röhrich
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • magnetic resonance imaging (MRI)
  • magnetic resonance spectroscopy (MRS)
  • metabolic imaging
  • X-nuclei
  • functional MRI (fMRI)
  • chemical exchange saturation transfer (CEST)
  • positron emission tomography (PET)
  • fibroblast activation protein inhibitor (FAPi)
  • ultra-high field (UHF)

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694